Premium
Fulgent Genetics Inc (FLGT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-27 | Mr. Jian XieCOO & President | -1,20k | 21,14k | Vente | 17,60 | 590,57k | -0,20% |
| 2026-05-26 | Mr. Paul KimCFO | -1,17k | 20,64k | Sale to Issuer | 17,67 | 364,63k | -0,32% |
| 2026-05-27 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -945,00 | 16,63k | Vente | 17,60 | 992,06k | -0,10% |
| 2026-05-26 | Mr. Ming HsiehChairman & CEO | -2,95k | 52,11k | Sale to Issuer | 17,67 | 8,86M | -0,03% |
| 2026-04-26 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -1,65k | 26,83k | Sale to Issuer | 16,31 | 993,01k | -0,17% |
| 2026-04-26 | Mr. Jian XieCOO & President | -4,36k | 71,13k | Sale to Issuer | 16,31 | 591,77k | -0,73% |
| 2026-04-26 | Mr. Paul KimCFO | -2,75k | 44,80k | Sale to Issuer | 16,31 | 365,80k | -0,75% |
| 2026-03-09 | Mr. Ming HsiehChairman & CEO | -750,00k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-02-26 | Mr. Paul KimCFO | -10,65k | 174,25k | Sale to Issuer | 15,33 - 24,76 | 368,55k | -2,81% |
| 2026-02-26 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -8,33k | 136,08k | Sale to Issuer | 15,33 - 24,76 | 926,05k | -0,89% |
| 2026-02-26 | Mr. Jian XieCOO & President | -10,37k | 169,66k | Sale to Issuer | 15,33 - 24,76 | 501,27k | -2,03% |
| 2026-02-26 | Mr. Ming HsiehChairman & CEO | -20,52k | 342,30k | Sale to Issuer | 15,33 - 24,76 | 8,86M | -0,23% |
| 2026-02-23 | Mr. Jian XieCOO & President | -26,82k | 619,29k | Sale to Issuer | 23,01 - 23,09 | 492,42k | -5,17% |
| 2026-02-23 | Mr. Paul KimCFO | -27,45k | 633,84k | Sale to Issuer | 23,01 - 23,09 | 276,96k | -9,02% |
| 2026-02-23 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -15,70k | 362,53k | Sale to Issuer | 23,01 - 23,09 | 918,02k | -1,68% |
| 2026-02-23 | Mr. Ming HsiehChairman & CEO | -65,51k | 1,51M | Sale to Issuer | 23,01 - 23,09 | 8,84M | -0,74% |
| 2026-01-26 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -1,33k | 36,64k | Sale to Issuer | 27,53 | 892,25k | -0,15% |
| 2026-01-26 | Mr. Paul KimCFO | -3,00k | 82,70k | Sale to Issuer | 27,53 | 328,15k | -0,91% |
| 2026-01-26 | Mr. Jian XieCOO & President | -4,71k | 129,69k | Sale to Issuer | 27,53 | 469,53k | -0,99% |
| 2025-12-01 | Mr. Paul KimCFO | -1,13k | 32,26k | Sale to Issuer | 28,52 | 331,15k | -0,34% |
| 2025-12-02 | Mr. Jian XieCOO & President | -1,14k | 32,30k | Vente | 28,33 | 245,34k | -0,46% |
| 2025-12-02 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -1,08k | 30,46k | Vente | 28,33 | 890,35k | -0,12% |
| 2025-11-28 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -943,00 | 27,88k | Vente | 29,57 | 889,42k | -0,11% |
| 2025-11-28 | Mr. Jian XieCOO & President | -1,20k | 35,42k | Vente | 29,57 | 244,48k | -0,49% |
| 2025-11-26 | Mr. Paul KimCFO | -1,17k | 35,15k | Sale to Issuer | 30,15 | 332,28k | -0,35% |
| 2025-11-26 | Mr. Ming HsiehChairman & CEO | -2,94k | 88,76k | Sale to Issuer | 30,15 | 8,79M | -0,03% |
| 2025-11-23 | Mr. Paul KimCFO | -671,00 | 20,13k | Sale to Issuer | 30,00 | 333,45k | -0,20% |
| 2025-11-24 | Mr. Jian XieCOO & President | -681,00 | 20,75k | Vente | 30,47 | 242,35k | -0,28% |
| 2025-11-24 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -535,00 | 16,30k | Vente | 30,47 | 887,59k | -0,06% |
| 2025-11-23 | Mr. Ming HsiehChairman & CEO | -2,12k | 63,48k | Sale to Issuer | 30,00 | 8,78M | -0,02% |
| 2025-11-19 | Mr. Jian XieCOO & President | -10,00k | 290,98k | Vente | 29,10 | 243,03k | -3,95% |
| 2025-11-19 | Mr. Jian XieCOO & President | -10,00k | 0,00 | Other Disposition | - | 243,03k | -3,95% |
| 2025-10-26 | Mr. Paul KimCFO | -2,74k | 65,12k | Sale to Issuer | 23,74 | 334,12k | -0,81% |
| 2025-10-26 | Mr. Jian XieCOO & President | -4,35k | 103,34k | Sale to Issuer | 23,74 | 263,03k | -1,63% |
| 2025-10-26 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -1,64k | 38,98k | Sale to Issuer | 23,74 | 888,12k | -0,18% |
| 2025-09-03 | Mr. Jian XieCOO & President | -1,13k | 24,85k | Vente | 22,03 | 259,30k | -0,43% |
| 2025-09-03 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -1,06k | 23,41k | Vente | 22,03 | 886,53k | -0,12% |
| 2025-09-01 | Mr. Paul KimCFO | -1,13k | 25,07k | Sale to Issuer | 22,17 | 336,86k | -0,33% |
| 2025-08-27 | Mr. Jian XieCOO & President | -1,20k | 25,76k | Vente | 21,48 | 258,43k | -0,46% |
| 2025-08-26 | Mr. Ming HsiehChairman & CEO | -2,94k | 63,21k | Sale to Issuer | 21,47 | 8,78M | -0,03% |
| 2025-08-26 | Mr. Paul KimCFO | -1,17k | 25,03k | Sale to Issuer | 21,47 | 337,99k | -0,34% |
| 2025-08-27 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -943,00 | 20,26k | Vente | 21,48 | 885,60k | -0,11% |
| 2025-08-23 | Mr. Ming HsiehChairman & CEO | -2,12k | 46,04k | Sale to Issuer | 21,77 | 8,78M | -0,02% |
| 2025-08-25 | Mr. Jian XieCOO & President | -696,00 | 14,97k | Vente | 21,50 | 257,52k | -0,27% |
| 2025-08-23 | Mr. Paul KimCFO | -670,00 | 14,59k | Sale to Issuer | 21,77 | 339,16k | -0,20% |
| 2025-08-25 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -548,00 | 11,78k | Vente | 21,50 | 884,78k | -0,06% |
| 2025-08-01 | Mr. Ming HsiehChairman & CEO | -1,34k | 24,81k | Sale to Issuer | 18,53 | 8,78M | -0,02% |
| 2025-07-26 | Mr. Paul KimCFO | -2,74k | 50,39k | Sale to Issuer | 18,37 | 339,83k | -0,80% |
| 2025-07-26 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -1,64k | 30,16k | Sale to Issuer | 18,37 | 884,31k | -0,19% |
| 2025-07-26 | Mr. Jian XieCOO & President | -4,35k | 79,95k | Sale to Issuer | 18,37 | 257,00k | -1,67% |
| 2025-06-09 | Mr. Ming HsiehChairman & CEO | -800,00k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-06-01 | Mr. Paul KimCFO | -1,13k | 23,43k | Sale to Issuer | 20,72 | 342,57k | -0,33% |
| 2025-06-02 | Mr. Jian XieCOO & President | -1,14k | 23,03k | Vente | 20,29 | 253,27k | -0,45% |
| 2025-06-02 | Dr. Hanlin GaoChief Scientific Officer & Lab Director | -754,00 | 15,30k | Vente | 20,29 | 882,72k | -0,09% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
